Skip to main content
    B

    Biomea Fusion Inc (BMEA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.49
    -0.03 (-6.17%)

    Market Cap: $42.31M

    Last updated: Nov 17, 2026 at 4:32 PM ET

    Biomea Fusion Inc (BMEA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Biomea Fusion (BMEA) has a market cap of $42.31M and an enterprise value of $15.91M. Its share count is up 21.29% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 62.40% below the market cap, as cash exceeds debt.

    Market Cap$42.31M
    Enterprise Value$15.91M
    Latest price (Nov 17, 2026)$0.49

    Key Dates

    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.32% in the quarter ended Sep 30, 2026 and grew 41.57% a year over 2 years.

    Shares Outstanding72.59M
    Shares Change (YoY)+21.29%
    Shares Change (QoQ)+0.32%
    Share Count Growth (2Y CAGR)+41.57%

    Price Statistics

    The stock is down 61.88% over 52 weeks and trades 54.21% below its 50-day average.

    Beta (1Y)1.60
    52-Week Change-61.88%
    1-Month Change-41.59%
    3-Month Change-64.89%
    6-Month Change-60.00%
    5-Year Change-94.05%
    Total Return (1Y)-61.88%
    Total Return (3Y CAGR)-63.92%
    Total Return (5Y CAGR)-46.63%
    Max Drawdown (1Y)-77.92%
    Max Drawdown (3Y)-97.54%
    Sharpe Ratio (1Y)-0.93
    Correlation with SPY (1Y)0.23
    50-Day Average$1.07
    200-Day Average$1.33
    52-Week Range$0.52 to $2.24
    RSI (14 Days)28.6
    Average Volume (20 Days)1.13M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.17x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.17x
    Quick Ratio2.17x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -433.36% and return on assets is -117.01% over the last 12 months.

    Return on Equity (ROE)-433.36%
    Return on Assets (ROA)-117.01%
    ROA (5Y Average)-84.60%

    Scores

    BMEA has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$47.00K
    Operating Income-$50.22M
    Pretax Income-$32.88M
    Net Income-$32.88M
    Reported EPS (TTM)-$0.50

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.01% of the $28.10M in total assets.

    Cash and Equivalents$26.40M
    Total Debt$0
    Net Cash$26.40M
    Net Cash Per Share$0.36
    Working Capital$14.89M
    Shareholder Equity$7.59M
    Book Value Per Share$0.10
    Total Assets$28.10M
    Total Liabilities$20.51M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$44.07M
    FCF Per Share-$0.61
    Depreciation and Amortization$123.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-70.61%
    Tangible Book Per Share Growth (2Y CAGR)-70.61%

    Revenue and profit by year

    Dividends and Yields

    BMEA does not pay a dividend.

    Buyback Yield-63.60%
    Shareholder Yield-63.60%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About BMEA

    What is BMEA's market cap?

    Biomea Fusion has a market cap of $42.31M. Its enterprise value, which adds debt and subtracts cash, is $15.91M.

    How many shares of BMEA are outstanding?

    Biomea Fusion has 72.59M shares outstanding. The count is up 21.29% from a year earlier.

    Does BMEA pay a dividend?

    No. Biomea Fusion does not pay a dividend.

    How much debt does BMEA have?

    Biomea Fusion has $0 of total debt and $26.40M of cash and equivalents, a net cash position of $26.40M.